BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24040098)

  • 1. SIL-TAL1 rearrangement is related with poor outcome: a study from a Chinese institution.
    Wang D; Zhu G; Wang N; Zhou X; Yang Y; Zhou S; Xiong J; He J; Jiang L; Li C; Xu D; Huang L; Zhou J
    PLoS One; 2013; 8(9):e73865. PubMed ID: 24040098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Characteristics and Treatment Efficacy of Children with SIL/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia].
    Liu X; Li WJ; Zhao XX; Gao C; Zhao W; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Cui L; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):681-6. PubMed ID: 27342490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of 19 patients with SIL-TAL1-positive T-cell acute lymphoblastic leukemia].
    Wang LJ; Chen Y; Xiang M; Yang XF; Chen SN
    Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):132-136. PubMed ID: 36948867
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlation between expression of SIL-TAL1 fusion gene and deletion of 6q in T-cell acute lymphoblastic leukemia].
    Wang Q; Wu LL; Dai HP; Ping NN; Wu CX; Pan JL; Cen JN; Qiu HY; Chen SN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1508-13. PubMed ID: 25543465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
    Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
    Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of monitoring the expression of the SIL-TAL1 fusion gene in T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Zhao X; Hong Y; Qin Y; Xu Y; Chang Y; Wang Y; Zhang X; Xu L; Huang X
    Int J Lab Hematol; 2017 Dec; 39(6):613-619. PubMed ID: 28736882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group.
    D'Angiò M; Valsecchi MG; Testi AM; Conter V; Nunes V; Parasole R; Colombini A; Santoro N; Varotto S; Caniglia M; Silvestri D; Consarino C; Levati L; Magrin E; Locatelli F; Basso G; Foà R; Biondi A; Cazzaniga G
    Haematologica; 2015 Jan; 100(1):e10-3. PubMed ID: 25304610
    [No Abstract]   [Full Text] [Related]  

  • 8. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 9. TAL1 expression does not occur in the majority of T-ALL blasts.
    Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
    Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
    Curry JD; Smith MT
    Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test.
    van der Burg M; Smit B; Brinkhof B; Barendregt BH; Verschuren MC; Dib M; Beverloo HB; van Dongen JJ; Langerak AW
    Leukemia; 2002 Apr; 16(4):755-61. PubMed ID: 11960364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.
    Sabir N; Iqbal Z; Aleem A; Awan T; Naeem T; Asad S; Tahir AH; Absar M; Hasanato RM; Basit S; Chishti MA; Faiyaz Ul-Haque M; Khalid AM; Sabar MF; Rasool M; Karim S; Khan M; Samreen B; Akram AM; Siddiqi MH; Shahzadi S; Shahbaz S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Iqbal M; Akhtar T
    Asian Pac J Cancer Prev; 2012; 13(7):3349-55. PubMed ID: 22994759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.
    Bash RO; Crist WM; Shuster JJ; Link MP; Amylon M; Pullen J; Carroll AJ; Buchanan GR; Smith RG; Baer R
    Blood; 1993 Apr; 81(8):2110-7. PubMed ID: 8471769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
    Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
    Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
    BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrequent erythrophagocytosis by leukemic blasts in de novo T-lymphoblastic leukemia with SIL-TAL1: A rare pediatric case.
    Li T; Su L; Li X; Zhang Y; Li L; Zhu J
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30544. PubMed ID: 37407425
    [No Abstract]   [Full Text] [Related]  

  • 18. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
    Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
    Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
    Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
    Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variant fusion transcripts and genomic DNA breakpoint of sil-tal1 in T-ALL cells].
    Zhao XX; Liang LJ; Ding W; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):174-9. PubMed ID: 21362246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.